PortfoliosLab logoPortfoliosLab logo
USRD vs. IBID
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

USRD vs. IBID - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Themes US R&D Champions ETF (USRD) and iShares iBonds Oct 2027 Term TIPS ETF (IBID). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, USRD achieves a 10.76% return, which is significantly higher than IBID's 1.94% return.


USRD

1D
-1.60%
1M
-2.04%
YTD
10.76%
6M
9.67%
1Y
19.51%
3Y*
5Y*
10Y*

IBID

1D
-0.05%
1M
-0.25%
YTD
1.94%
6M
2.03%
1Y
3.92%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

USRD vs. IBID - Yearly Performance Comparison


2026 (YTD)202520242023
USRD
Themes US R&D Champions ETF
10.76%12.44%15.53%5.32%
IBID
iShares iBonds Oct 2027 Term TIPS ETF
1.94%5.66%4.71%1.46%

Correlation

The correlation between USRD and IBID is -0.11, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.11

Correlation (All Time)
Calculated using the full available price history since Dec 13, 2023

-0.01

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

USRD vs. IBID — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

USRD
USRD Risk / Return Rank: 3232
Overall Rank
USRD Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
USRD Sortino Ratio Rank: 3131
Sortino Ratio Rank
USRD Omega Ratio Rank: 3131
Omega Ratio Rank
USRD Calmar Ratio Rank: 3131
Calmar Ratio Rank
USRD Martin Ratio Rank: 3232
Martin Ratio Rank

IBID
IBID Risk / Return Rank: 9595
Overall Rank
IBID Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
IBID Sortino Ratio Rank: 9696
Sortino Ratio Rank
IBID Omega Ratio Rank: 9595
Omega Ratio Rank
IBID Calmar Ratio Rank: 9595
Calmar Ratio Rank
IBID Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

USRD vs. IBID - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Themes US R&D Champions ETF (USRD) and iShares iBonds Oct 2027 Term TIPS ETF (IBID). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


USRDIBIDDifference
Sharpe ratioReturn per unit of total volatility

-2.09

Sortino ratioReturn per unit of downside risk

-3.81

Omega ratioGain probability vs. loss probability

1.20

1.72

-0.52

Calmar ratioReturn relative to maximum drawdown

1.45

7.20

-5.75

Martin ratioReturn relative to average drawdown

4.25

29.14

-24.89

USRD vs. IBID - Sharpe Ratio Comparison

The current USRD Sharpe Ratio is 1.10, which is lower than the IBID Sharpe Ratio of 3.19. The chart below compares the historical Sharpe Ratios of USRD and IBID, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

USRD vs. IBID - Drawdown Comparison

The maximum USRD drawdown since its inception was -23.79%, which is greater than IBID's maximum drawdown of -1.28%. Use the drawdown chart below to compare losses from any high point for USRD and IBID.


Loading charts...

Drawdown Indicators


USRDIBIDDifference

Max Drawdown

Largest peak-to-trough decline

-23.79%

-1.28%

-22.51%

Max Drawdown (1Y)

Largest decline over 1 year

-13.49%

-0.55%

-12.94%

Current Drawdown

Current decline from peak

-8.69%

-0.55%

-8.14%

Average Drawdown

Average peak-to-trough decline

-3.75%

-0.22%

-3.53%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.60%

0.13%

+4.47%

Volatility

USRD vs. IBID - Volatility Comparison

Themes US R&D Champions ETF (USRD) has a higher volatility of 8.56% compared to iShares iBonds Oct 2027 Term TIPS ETF (IBID) at 0.35%. This indicates that USRD's price experiences larger fluctuations and is considered to be riskier than IBID based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


USRDIBIDDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.56%

0.35%

+8.21%

Volatility (6M)

Calculated over the trailing 6-month period

14.73%

0.86%

+13.87%

Volatility (1Y)

Calculated over the trailing 1-year period

17.86%

1.23%

+16.63%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.52%

2.24%

+17.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.52%

2.24%

+17.28%

USRD vs. IBID - Expense Ratio Comparison

USRD has a 0.29% expense ratio, which is higher than IBID's 0.10% expense ratio.


Dividends

USRD vs. IBID - Dividend Comparison

USRD's dividend yield for the trailing twelve months is around 0.38%, less than IBID's 3.68% yield.


PositionTTM202520242023
IBID
iShares iBonds Oct 2027 Term TIPS ETF
3.68%4.43%4.24%0.81%
USRD
Themes US R&D Champions ETF
0.38%0.42%2.44%0.00%

Frequently Asked Questions


USRD and IBID have a correlation of -0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

USRD has higher volatility (8.56%) compared to IBID (0.35%). In terms of maximum drawdown, USRD dropped -23.79% vs IBID's -1.28%.

On 1-year performance, USRD leads with 19.51% vs 3.92% for IBID. On fees, IBID is cheaper at 0.10% per year. On volatility, IBID has been the lower-risk option at 0.35%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, USRD has performed better with a 19.51% return vs 3.92%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IBID is cheaper with a 0.10% expense ratio, compared with 0.29% for USRD.

IBID has the higher dividend yield at 3.68%, compared with 0.38% for USRD.

USRD is categorized as Large Cap Blend Equities, while IBID is Inflation-Protected Bonds. USRD tracks Solactive US R&D Champions Index, while IBID tracks ICE 2027 Maturity US Inflation-Linked Treasury Index. They also come from different issuers: Themes and iShares. Their fees differ too: 0.29% for USRD and 0.10% for IBID.

IBID currently has the higher Sharpe Ratio (3.19 vs 1.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for USRD and IBID

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer